Kv1.3
Meet in Italy for Life Sciences - Awards

We are happy and thrilled to announce that our Kv1.3 pitch was chosen as "Best Innovative Business Proposal" by a board of investors on Startup Breeding, an annual event of Cluster Nazionale Scienze della Vita ALISEI, the Italian National Cluster for Life Sciences.

Furthermore, we received the Special Awards of 2i3T - Innovative Companies Incubator of the University of Turin and Bioindustry Park Silvano Fumero S.p.A. Società Benefit.

Introduction
Link icon purple
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
November 2, 2023
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
November 2, 2023
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
Introduction
Link icon purple
Latest
News
The latest industry news, interviews, technologies, and resources.
View All News
Conference
January 28, 2026
By VRG Therapeutics
2026 International Roadshow Begins
White arrow icon up and right direction redirecting to Partner with US page
Team
January 18, 2026
By VRG Therapeutics
New Joiner R&D Director of Dug Discovery
White arrow icon up and right direction redirecting to Partner with US page
Latest
News
The latest industry news, interviews, technologies, and resources.
Conference
January 28, 2026
By VRG Therapeutics
2026 International Roadshow Begins
White arrow icon up and right direction redirecting to Partner with US page
Team
January 18, 2026
By VRG Therapeutics
New Joiner R&D Director of Dug Discovery
White arrow icon up and right direction redirecting to Partner with US page
View All News
Learn More
Million ways to improve life
Learn More
Million ways to improve life